Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters

This is particularly relevant for vegetarians, vegans, and older adults who are at a higher risk of deficiency due to their dietary choices or absorption issues
The lack of blood supply to the heart may cause heart attacks and the lack of blood supply to the brain accelerates the development of dementia and may lead to strokes (3, 4)
At Blooming Wellness & Weightloss, we are dedicated to providing comprehensive health solutions to support your wellness journey
Changes in markers, pathways, or models do not automatically establish reduced swelling, less discomfort, better healing, improved function, or faster recovery in humans
(2018) described MOTS-c as a systemic insulin sensitizer that acts across multiple tissues, including skeletal muscle, adipose, and potentially the brain [7]